Integrated Proteins Limited has issued a clarification to BSE Limited regarding recent significant movement observed in its share price, responding to an exchange inquiry dated March 2, 2026.

Company's Response to Price Movement Inquiry

The company addressed the BSE's concerns about unusual price activity in its securities through a formal communication dated March 10, 2026. Company Secretary Girish Kalwani signed the response, confirming the company's awareness of its regulatory obligations.

Regulatory Compliance Confirmation

Integrated Proteins emphasized its full compliance with disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated it has been regularly informing stock exchanges of all material events and price-sensitive information as mandated by applicable regulations.

After conducting due verification, the company confirmed it is not aware of any undisclosed events or information that could influence the price or volume behavior of its securities. The company assured that all material information requiring disclosure has already been shared with stock exchanges.

Market-Driven Movement Attribution

The company attributed the recent share price movement to market-driven factors and prevailing market conditions. Key points from the clarification include:

• No undisclosed material events affecting share price
• Movement appears purely market-driven
• Company not connected with price movement
• Full compliance with SEBI disclosure regulations maintained

The clarification serves to address investor concerns and maintain transparency regarding the company's securities trading activity.

Integrated proteins Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a challenging third quarter performance. The Gujarat-based company reported a net loss during the quarter, marking a significant shift from the profitable performance in the corresponding period of the previous year.

Financial Performance Overview

The company's quarterly performance showed notable deterioration across key metrics. The most striking aspect was the complete absence of operational revenue during the quarter, which significantly impacted overall profitability.

Nine-Month Performance Analysis

Despite the challenging third quarter, the nine-month performance presented a different picture. The company demonstrated substantial operational activity during the first half of the fiscal year.

Expense Structure and Operational Metrics

The company's expense profile during Q3FY26 remained minimal, reflecting the absence of operational activity. Total expenses for the quarter stood at ₹1.55 lakh, comprising primarily employee benefit expenses of ₹0.60 lakh and other expenses of ₹0.95 lakh. This contrasted with Q3FY25 expenses of ₹4.71 lakh.

For the nine-month period, the company incurred total expenses of ₹421.41 lakh, with purchases of stock-in-trade representing the largest component at ₹404.45 lakh. Employee benefit expenses totaled ₹2.62 lakh, while other expenses amounted to ₹14.35 lakh.

Capital Structure and Share Information

The company maintained a stable capital structure throughout the reporting period:

Fund Utilization and Corporate Actions

The company provided details regarding fund utilization from its preferential issue. The total amount raised was ₹1744.88 lakh through preferential issues conducted on multiple dates in January and February 2025. The funds were allocated for capital expenditure (₹1054.75 lakh) and exploring new initiatives (₹690.13 lakh), with the company reporting full utilization of the raised amount.

Board Meeting and Regulatory Compliance

The Board of Directors meeting was held on February 12, 2026, from 4:30 PM to 5:00 PM, where directors considered and approved the unaudited financial results. The results were reviewed by the Audit Committee before board approval and underwent limited review by statutory auditors B.B. Gusani & Associates, Chartered Accountants. The company confirmed compliance with Indian Accounting Standard 34 for interim financial reporting and SEBI listing regulations.